The birth control ingredient name-dropped in Project 2025 is suddenly getting new attention, thanks to research suggesting it could serve as a mifepristone substitute.

The drop in confidence comes as the Supreme Court debates the future of the abortion pill.

On abortion medication, the justices would have very good reasons to leave the status quo intact for FDA drug approvals.

A Texas judge’s decision on access to medication abortion has reproductive rights advocates on edge and providers bracing for a fresh round of chaos.

The retail health care giant instructed pharmacies to check why customers need medications such as methotrexate—and to refuse to provide them if they can’t prove they’re not for an abortion.

Telehealth has grown increasingly common in the face of Covid-19. A federal judge has now extended that access to medication abortion.

“I remember one woman who arrived and asked, ‘Is this the clinic?’ And we were like, ‘What clinic?’”

Our future might look much like our past, with pills as a major part of abortion access—and an obsessive target for abortion opponents.